GeneDx Study Shows Hospital-Wide Rapid Genome Sequencing Can Improve Pediatric Diagnosis, Outcomes and Health System Efficiency GeneDx (Nasdaq: WGS), a company focused on rare disease diagnosis and the use of…
Spruce Biosciences Advances Toward 2026 BLA Submission for Tralesinidase Alfa in Sanfilippo Syndrome Type B Spruce Biosciences, Inc., a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies for…
AN2 Therapeutics Appoints Cameron Trenor, M.D., as Chief Medical Officer to Advance Clinical Development Pipeline AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing novel small molecule therapeutics through…
TwinStrand Biosciences Secures More Than $245 Million Judgment in Patent Infringement Case Against Guardant Health TwinStrand Biosciences, Inc., the developer of Duplex Sequencing® technology, announced that the U.S. District Court…
European Commission Broadens Trodelvy’s First-Line Use in Metastatic Triple-Negative Breast Cancer Regardless of PD-L1 Status Gilead Sciences, Inc.announced that the European Commission (EC) has granted marketing authorization for Trodelvy® (sacituzumab…
Precision BioSciences Doses First Patient in Phase 1/2 FUNCTION-DMD Trial of PBGENE-DMD for Duchenne Muscular Dystrophy Precision BioSciences, Inc., a clinical-stage gene editing company developing in vivo therapies for diseases…
Daiichi Sankyo Appoints Ken Keller as Chief Commercialization Officer to Accelerate Global Oncology and Specialty Medicine Growth Daiichi Sankyo has announced the appointment of Ken Keller to the newly created…
ORZEYFUL (oveporexton) Gains Japanese Approval as the First and Only Medicine Addressing the Underlying Cause of Narcolepsy Type 1 Takeda has announced that Japan’s Ministry of Health, Labour and Welfare…
AbbVie Highlights New Lung Cancer Research Data Across NSCLC and SCLC Programs at WCLC 2026 AbbVie is showcasing a broad collection of new research findings across its lung cancer development…
Genentech to Invest $750 Million in New Device Fill-Finish Manufacturing Facility in Oregon Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), has announced plans to invest…
Integrated DNA Technologies Expands DNA Synthesis Capabilities to Support Genomics Programs Across Scale and Complexity Integrated DNA Technologies (IDT), a Danaher company and global provider of genomics solutions, has announced…
bioAffinity Technologies Announces 1-for-15 Reverse Stock Split to Support Nasdaq Compliance bioAffinity Technologies, Inc., a biotechnology company developing noninvasive technologies for the detection of early-stage cancer, has announced that it…